AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 33 filers reported holding AVALO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $105,000 | – | 60,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 3,964,666 | $19,982,313 | 0.35% |
| Nantahala Capital Management | 540,667 | $2,725,016 | 0.18% |
| Point72 Asset Management, L.P. | 500,737 | $2,523,765 | 0.01% |
| MEEDER ASSET MANAGEMENT INC | 1,507 | $7,595 | 0.00% |
| TCI Wealth Advisors, Inc. | 251 | $1,265 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 10 | $50 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 6 | $30 | 0.00% |
| WELLS FARGO & COMPANY/MN | 131 | $660 | 0.00% |
| NORTHERN TRUST CORP | 10,855 | $54,710 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |